These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 26678807)

  • 1. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
    Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
    Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.
    Wisniewski PJ; Dowden RA; Campbell SC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
    Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
    Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids in the gastrointestinal tract.
    Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue.
    Cani PD
    Clin Microbiol Infect; 2012 Jul; 18 Suppl 4():50-3. PubMed ID: 22647050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, obesity and diabetes.
    Patterson E; Ryan PM; Cryan JF; Dinan TG; Ross RP; Fitzgerald GF; Stanton C
    Postgrad Med J; 2016 May; 92(1087):286-300. PubMed ID: 26912499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the endocannabinoid system with microbial interventions to improve gut integrity.
    Jansma J; Brinkman F; van Hemert S; El Aidy S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110169. PubMed ID: 33186639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis.
    De Filippo C; Costa A; Becagli MV; Monroy MM; Provensi G; Passani MB
    Front Endocrinol (Lausanne); 2023; 14():1135157. PubMed ID: 37091842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond.
    Cani PD; Geurts L; Matamoros S; Plovier H; Duparc T
    Diabetes Metab; 2014 Sep; 40(4):246-57. PubMed ID: 24631413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis.
    Cluny NL; Reimer RA; Sharkey KA
    Brain Behav Immun; 2012 Jul; 26(5):691-8. PubMed ID: 22269477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract.
    Lian J; Casari I; Falasca M
    Pharmacol Res; 2022 Jan; 175():106025. PubMed ID: 34883211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
    Swanson HI
    Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.
    Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Guaza C
    Biochem Pharmacol; 2018 Nov; 157():51-66. PubMed ID: 30171835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine.
    Smid SD
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1383-7. PubMed ID: 18671715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.
    Storr MA; Yüce B; Andrews CN; Sharkey KA
    Neurogastroenterol Motil; 2008 Aug; 20(8):857-68. PubMed ID: 18710476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.